Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PharmAsia News Notable Notes: Japan’s Rising Health Care Funding Gap

This article was originally published in PharmAsia News

Executive Summary

Japanese policy makers should reconsider the country's National Health Insurance plan, which focuses on constraining costs rather than the scope of treatment, if they are to avoid a funding gap created by rising health care costs, according to a report by the economic research and consulting firm McKinsey Global Institute

You may also be interested in...



Japan Unlikely To Relax Dispensing Limits On New Drugs

TOKYO - Even though Japan relaxed prescription drug-dispensing periods in 2002, it continues to limit dispensing for narcotics and for new drugs during the first year of launch - a regulation the U.S. believes is a barrier to trade that inconveniences patients and doctors

Japan Unlikely To Relax Dispensing Limits On New Drugs

TOKYO - Even though Japan relaxed prescription drug-dispensing periods in 2002, it continues to limit dispensing for narcotics and for new drugs during the first year of launch - a regulation the U.S. believes is a barrier to trade that inconveniences patients and doctors

Japan Sees Pharma Research as its Sunrise Sector, Alters Policy to Rev up R&D

TOKYO - The Japanese Ministry of Health, Labor and Welfare will seek budgetary appropriations or allocations for 2009 to extend research funds to companiesfor developing break-though pharmaceutical products as a national project, according to a MHLW official Aug. 5

Related Content

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel